“…In 2015, several isolated xanthones from the branches of Garcinia achachairu were investigated as the anticancer agents against nasopharynx cancer cells (CNE-1, CNE-2, and SUNE1). A new prenylated xanthone (35) showed a remarkable anticancer activity with the IC 50 of 1.43, 0.73, and 2.23 µM against CNE-1, CNE-2, and SUNE1 cell lines, respectively. On the other hand, the anticancer activity of compound 36 was evaluated against U-251, MCF-7, NCI/ADR-RES, 786-0, NCI-H460, PC-3, HT-29, and HaCat cell lines, giving IC 50 values of 11.2, 34.0, 8.61, 19.6, 56.2, 10.5, 58.1, and 30.6 µM, respectively, which was comparable to doxorubicin [176].…”